Skip to main content

Day: November 10, 2023

Form 8.3 – Picton Property Income Limited

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Rathbones Group Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree PICTON PROPERTY INCOME LTD(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening...

Continue reading

Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum

REDWOOD CITY, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced company management will be participating in the upcoming Canaccord MedTech, Diagnostics and Digital Health and Services Forum in New York, NY. Seer’s management is scheduled to present on Thursday, November 16th at 1:00 p.m. Eastern Time / 10:00 a.m. Pacific Time. A live webcast of the session will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the conference. About SeerSeer is a life sciences company developing transformative products that open a new gateway to the proteome. Seer’s Proteograph™ Product Suite is an integrated solution that...

Continue reading

Stran & Company to Present at the Sidoti Virtual Investor Conference on November 16th

Quincy, MA, Nov. 10, 2023 (GLOBE NEWSWIRE) — Stran & Company, Inc. (“Stran” or the “Company”) (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise, today announced that Andy Shape, President and Chief Executive Officer of Stran, will be presenting at the Sidoti Investor Conference being held virtually on November 15-16, 2023. Mr. Shape is scheduled to present at 10:00 a.m. Eastern Time on Thursday, November 16, 2023. The presentation will be webcast live and available for replay at https://sidoti.zoom.us/webinar/register/WN_WdAMna7rS_mS8W83ocCsdQ. Mr. Shape will also be available for one-on-one meetings with qualified investors throughout the conference. To register for the conference, please visit...

Continue reading

Music Licensing, Inc. (OTC:SONG) Celebrates Remarkable Achievement: CEO Jake P. Noch Commits to Cancelling 59.9% of Outstanding Shares, Enhancing Shareholder Value!”

Naples, FL, Nov. 10, 2023 (GLOBE NEWSWIRE) — Music Licensing, Inc. (OTC: SONG), a beacon of innovation in the music industry, proudly announces a momentous commitment from our CEO, Jake P. Noch. Following the cancellation of an astounding 1,566,945,290 common stock shares, which reduced the total outstanding shares to 2,000,000,000, Mr. Noch is now embarking on yet another groundbreaking endeavor. He has pledged to cancel an additional 1,197,364,785 common stock shares, equating to a remarkable 59.9% of the current outstanding shares. This strategic move represents a significant leap forward in our mission to enhance shareholder value and strengthen the company’s financial foundation. By reducing the number of outstanding shares by almost 60%, Music Licensing, Inc. is poised for unprecedented growth and stability. Shareholders...

Continue reading

Sampo plc: Managers’ Transactions (Lamminen)

SAMPO PLC                        MANAGERS’ TRANSACTIONS                    10 November 2023 at 4:00 pm Sampo plc: Managers’ Transactions (Lamminen) Sampo plc (business code 0142213-3) has received the following notification under Article 19 of the Market Abuse Regulation. Shares have been acquired in accordance with the decision of Sampo’s Annual General Meeting on 17 May 2023. ____________________________________________ Person subject to the notification requirement Name: Johanna Lamminen Position: Member of the Board/Deputy member Issuer: Sampo plc LEI: 743700UF3RL386WIDA22 Notification type: INITIAL NOTIFICATION Reference number: 43223/6/6 ____________________________________________ Transaction date: 2023-11-09 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI4000552500 Nature of transaction: RECEIPT OF A SHARE-BASED...

Continue reading

WithSecure Corporation: Financial reporting schedule for 2024

WithSecure Corporation, Stock Exchange Release, 10 November 2023, 16:00 EET WithSecure Corporation: Financial reporting schedule for 2024 During the year 2024, WithSecure Corporation will publish financial information as follows13 February 2024: Financial Statement Release and Annual Report 2023 24 April 2024: Interim Report for January–March 2024 16 July 2024: Half-Year Financial Report for January–June 2024 23 October 2024: Interim Report for January–September 2024WithSecure observes at least a three-week (21 days) silent period prior to publication of financial reports, during which it refrains from engaging in discussions with capital market representatives or the media regarding WithSecure’s financial position or the factors affecting it. The Annual General Meeting is scheduled for Wednesday, 20 March 2024. The Board of Directors...

Continue reading

Envoy Medical Announces Publication of Additional Patent for Implantable Cochlear Systems

Newly Published Patent Contemplates an Evolving Product Portfolio to Serve the Under-Penetrated Hearing Implant Market WHITE BEAR LAKE, Minnesota, Nov. 10, 2023 (GLOBE NEWSWIRE) — Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a revolutionary hearing health company focused on fully implanted hearing systems, today announced that it has been awarded another patent. This patent – “Implantable Cochlear System with Inner Ear Sensor” (Document ID: US 11806531 B2) – is one of a growing number of patents that Envoy Medical has applied for or secured as part of its implantable hearing devices technology portfolio. “We are excited to announce this new patent, which gives us an additional opportunity to evolve and grow our designs over time. We’ve made no secret of our intent to disrupt the hearing implant market with our fully...

Continue reading

Martinrea International Inc. Recognized as 2023 Cadia Impact Awards Winner of Systemic Change and Winner of Leadership Commitment

2023 CADIA Impact Award – Systemic ChangeMartinrea team accepts the 2023 CADIA Impact Award receiving overall recognition in the category of Systemic Change. Photo Credit: CADIA/Nadir Ali.2023 CADIA Impact Award – Leadership CommitmentDeanna Lorincz, Global Director Communications and Marketing accepts the 2023 CADIA Impact Award receiving overall recognition in the category of Leadership Commitment. Photo Credit: CADIA/Nadir AliTORONTO, Nov. 10, 2023 (GLOBE NEWSWIRE) — Martinrea International Inc. (TSX : MRE), a diversified and global automotive supplier engaged in the design, development and manufacturing of highly engineered, value-added Lightweight Structures and Propulsion Systems, is excited to be a recipient of the 2023 CADIA Impact Awards. The company received an overall recognition in the category...

Continue reading

XPO Furthers Commitment to Military Hiring by Joining U.S. Army’s PaYS Program

GREENWICH, Conn. , Nov. 10, 2023 (GLOBE NEWSWIRE) — XPO (NYSE: XPO), a leading provider of freight transportation in North America, announced today that it is strengthening its ongoing commitment to military hiring by entering into a strategic partnership with the U.S. Army Partnership for Your Success (PaYS) program. The partnership offers regular and Reserve soldiers job interviews and potential employment after completing their service in the Army. XPO and the Army will hold a signing ceremony for this commitment on November 15th.  “With more than 2,000 veterans and active service members on our team, XPO is a proud, military-friendly workplace,” said Mario Harik, CEO of XPO. “We place exceptional value on the outstanding skill set and dedication that military-trained employees bring to our company, and we...

Continue reading

Local Investors Announce Major St. Louis-Area Real Estate Acquisition

ST. LOUIS, Nov. 10, 2023 (GLOBE NEWSWIRE) — A group of local investors, led by Jerry Kent and the Cequel III Family Office, today announced the acquisition of 10 premier office buildings in West St. Louis County, encompassing nearly 1 million square feet of rentable space. The seller and purchase price were not disclosed. The acquired buildings include eight in the Maryville Centre office complex (520, 530, 540, 550, 625, 635, 645, and 655 Maryville Centre Drive) and two in the Woodsmill Commons office complex (400 and 424 South Woods Mill Road). St. Louis-based Cozad Commercial Real Estate will lease and manage the buildings. “Approaching four years since the pandemic started, a growing number of companies have now established robust, hybrid work arrangements for their teams, resulting in more people returning to collective office...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.